DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	TNFRSF13B; LILRA1; EGFR; F2; IFNG; IL2RA; CD3D; ADRB2; CD3G; CCL2; EDN3; EDNRB; CXCR1; KLRC1; GLP1R; CXCR3; CCR5; ADGRE1; ADGRF1; ADGRG6; ADGRF2; LILRB2; CLEC1A; GLMN; ADGRE3; CLEC1B; CLEC4A; TRBV24-1; TRBV6-4; TRBV19; TRBV6-6; TRBV5-1; CD80; TRBV6-1; TRBV7-1; TRBV27; TRBV6-8; TRBV17; TRBV5-5; TRBV3-1; TRBV2; TRBV13; TRBV28; TRBV6-2; TRBV11-1; TRBV25-1; TRBV7-2; TRBV4-1; TRBV11-3; TRBV7-6; TRBV29-1; TRBV10-1; TRBV7-7; TRBV14; TRBV15; TRBV5-7; TRBV30; TRBV10-2; TRBV6-7; TRBV4-2; TRBV20-1; TRBV7-4; TRBV12-5; TRBV6-5; TRBV12-4; TRBV5-6; TRBV16; TRBV23-1; TRBV5-4; TRBV9; ANXA1; TRBV12-3; TRBV18; TRBV7-9; TRBV11-2; TRBV10-3;	GO:0007166~cell surface receptor signaling pathway	76	268	28.3582089552239	0	0	0	0	0	0	0
up	TRAV19; CD300LB; NCR3; TYROBP; LILRA1; NCR1; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; TRBV12-3; TRAV8-4; IGHV1-46; IGHV3-23; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGKC; TRBC1; CD3D; IGKV1-16; IGKV3-11; TRBV7-9; TRAV29DV5; IGKV2-30; IGKV4-1; IGHV4-34; CD3G; IGLC2; IGLC3; CD8B; CD19; IGHV1-2; KLRC1; CD1C; CD40LG; FCGR2B; ICAM3; KIR2DL1; KIR2DL3; KIR3DL1; KIR3DL2; IGLV3-21; CD300E; TREML2; LAIR2; TREML4; LILRB2; LILRB1; RAET1E; CD300LF; KIR2DL4; CD300A; SIGLEC7; BTNL8; HHLA2;	GO:0050776~regulation of immune response	67	216	31.0185185185185	0	0	0	0	0	0	0
down	TBX3; SOX15; SPDEF; IL33; TFAP2A; GLI2; GLI3; HOXD8; NR2F2; HOXC8; PCGF2; MSX2; MMP12; FRK; SOX9; HMGA2; DLX1; FOXL2; ISL1; NKX3-2; CAV1; TBX2; SIM2; SHH; SIX1; TWIST1; OSR1; GATA6; SMO; FOXC2; IRX2; TP63; TFCP2L1; TAGLN3; KCNIP3; LOXL2; HES7; DLX2; TBX18; HES2; NR0B2;	GO:0000122~negative regulation of transcription by RNA polymerase II	41	847	4.84061393152302	0	0	0	0	0	0	0
down	TLL1; KLK8; CFI; MMP2; MMP7; MMP10; CTSE; MMP12; KLK7; MMP16; FOLH1; WFDC2; HABP2; THSD4; SFRP1; ADAMTSL1; ADAMTS15; HTRA1; RHBDF1; PAPPA2; TINAGL1; FBXL2; KLK13; KLK5; CAPN8; CPA6; CAPN6; PLAT; PLAU; TRHDE;	GO:0006508~proteolysis	30	436	6.88073394495413	0	0	0	0	0	0	0
down	TGFB1I1; DSCAM; MPDZ; LAMC1; ITGB6; CDH3; TNC; LAMA1; THBS2; APLP1; EFNB2; CDH11; LGALS4; BCAR1; SRPX; COL16A1; LGALS3BP; SPOCK1; CNTN1; TPBG; COL4A6; DSG2; HABP2; POSTN; CERCAM; AMTN; PPFIBP1; COL12A1; NTM; LOXL2; PCDHB8; PCDHAC1; PCDHB13; PCDHB2; PCDHA10; PCDHAC2; PCDHA11; PCDHB10; PCDHGC5; PCDHGC3; PCDHB7; PCDHB16; PCDHB4; PCDHGB5; PCDHA12;	GO:0007155~cell adhesion	45	454	9.91189427312775	0	0	0	0	0	0	0
down	TLL1; SOX15; INHA; FGF1; INHBA; ROS1; ANXA13; FOXL2; BNC1; NHLH2; SIM2; ZNF423; NXN; OSR1; TWIST2; RBM24; RAI14; NDRG4; DLX1; DLX2; NKX2-8; HES7; NR2F2; FOXA2; SPINK6; FSTL3; CAV1; HNF4A; SPDEF; FOXD4; FOXC2; NKX3-2; HNF4G; FOXD1; FSTL1; FRK; HES2; NKX1-2; ONECUT2;	GO:0030154~cell differentiation	39	572	6.81818181818182	0	0	0	0	0	0	0
down	MATN3; COL4A1; COL5A2; COL4A2; LAMC1; COL11A1; ITGB6; TNC; LAMA1; FBN1; SERPINB5; SOX9; MFAP2; COL16A1; LOXL1; FOXF2; COL4A6; EGFLAM; PXDN; MMP2; MMP12; COL22A1; MMP10; MMP7; MMP16; POSTN;	GO:0030198~extracellular matrix organization	26	230	11.304347826087	0	0	0	0	0	0	0
down	KRT34; KRT75; KRT14; KRT6B; KRT8; IVL; KRT19; KRT16; FLG; SPRR1B; SPRR2E; SPRR2D; SPRR1A; SPRR2A; KRT20; KRT6C; KRT17; DSG2; KRT33B; KRT31; SPINK6; SPRR3; KLK13; KLK5;	GO:0070268~cornification	24	113	21.2389380530973	0	0	0	0	0	0	0
down	WNT5A; LHX1; FOXL2; TGFB2;	GO:0060065~uterus development	4	15	26.6666666666667	0.00010169915466395	0.00246033724167808	0.245400060204133	0.255875073134521	0.191499508232235	0.245400060204133	0.0206861218684057
down	INHA; INHBA; SFRP1;	GO:0045578~negative regulation of B cell differentiation	3	5	60	0.0001239627532017	0.0029148624958456	0.298998160722502	0.311890287055479	0.21718274360938	0.298750235216099	0.0245076974803589
down	NKX3-2; SHH; GATA6;	GO:0048645~animal organ formation	3	5	60	0.0001239627532017	0.0029148624958456	0.298998160722502	0.311890287055479	0.21718274360938	0.298750235216099	0.0245076974803589
down	LRP4; SHANK2; SHANK3;	GO:0051124~synaptic growth at neuromuscular junction	3	5	60	0.0001239627532017	0.0029148624958456	0.298998160722502	0.311890287055479	0.21718274360938	0.298750235216099	0.0245076974803589
down	NHLH2; SHH; KLK6; TAGLN3; TBX2; SMO; SOX9; TBX3; SPINK6;	GO:0007417~central nervous system development	9	133	6.76691729323308	0.00012688852544884	0.00295603268545637	0.305674457806262	0.319251530029288	0.220498073368511	0.305674457806262	0.0248538498472812
down	TGFB1I1; ONECUT2; WNT7B; GATA6; WNT9A; WNT5A;	GO:0045165~cell fate commitment	6	55	10.9090909090909	0.00015984504958988	0.00364636363072564	0.38474703436284	0.402170144768137	0.253668641895611	0.38474703436284	0.0306580419805644
down	SOX9; SHH; SIX1; SMO; SIX4;	GO:0034504~protein localization to nucleus	5	34	14.7058823529412	0.00016086898370848	0.00364636363072564	0.387050774802613	0.404746363010546	0.254635810520556	0.387050774802613	0.0306580419805644
down	CCK; NR2F2; MAP1B; SPOCK1; CDK5R2; TWIST1; ADGRL3; MARK1;	GO:0001764~neuron migration	8	109	7.3394495412844	0.0001775561825571	0.00398867281530065	0.427022619049834	0.446731355313673	0.269175172756569	0.427022619049834	0.0335361228342134
down	APOD; TNC; MAP1B;	GO:0014012~peripheral nervous system axon regeneration	3	6	50	0.00018410676244795	0.00402793577668744	0.442592656924885	0.463212614319056	0.274503182809901	0.442224443399989	0.0338662395313893
down	SOX9; DLX1; DLX2;	GO:0046533~negative regulation of photoreceptor cell differentiation	3	6	50	0.00018410676244795	0.00402793577668744	0.442592656924885	0.463212614319056	0.274503182809901	0.442224443399989	0.0338662395313893
down	INHA; INHBA; FOXL2;	GO:0046881~positive regulation of follicle-stimulating hormone secretion	3	6	50	0.00018410676244795	0.00402793577668744	0.442592656924885	0.463212614319056	0.274503182809901	0.442224443399989	0.0338662395313893
down	CTSE; SHH; PCSK9; KLK6;	GO:0016540~protein autoprocessing	4	18	22.2222222222222	0.0001859565311707	0.00403333303815082	0.446481631340864	0.467866632425495	0.275959492257327	0.446481631340864	0.0339116188421992
down	WNT9A; GDNF; DLX1; ISL1; DLX2;	GO:0045597~positive regulation of cell differentiation	5	36	13.8888888888889	0.00020485820213889	0.00440532680838846	0.491659685133339	0.51542323658145	0.291308363441503	0.491659685133339	0.0370392829424975
down	GLI2; MSX2; SHH; PTHLH;	GO:0002076~osteoblast development	4	19	21.0526315789474	0.00022274656038567	0.00459369136008497	0.534368998365242	0.560430345930366	0.304814453750654	0.533478012123699	0.0386230219543997
down	POSTN; SEMA6D; HAS2; NOX4;	GO:0014911~positive regulation of smooth muscle cell migration	4	19	21.0526315789474	0.00022274656038567	0.00459369136008497	0.534368998365242	0.560430345930366	0.304814453750654	0.533478012123699	0.0386230219543997
down	WNT5A; HES7; TP63; VANGL2;	GO:0036342~post-anal tail morphogenesis	4	19	21.0526315789474	0.00022274656038567	0.00459369136008497	0.534368998365242	0.560430345930366	0.304814453750654	0.533478012123699	0.0386230219543997
down	SERPINE2; NTF4; ISL1; SLITRK6;	GO:0060384~innervation	4	19	21.0526315789474	0.00022274656038567	0.00459369136008497	0.534368998365242	0.560430345930366	0.304814453750654	0.533478012123699	0.0386230219543997
down	TERT; HMGA2; TWIST1; PLK2;	GO:2000773~negative regulation of cellular senescence	4	19	21.0526315789474	0.00022274656038567	0.00459369136008497	0.534368998365242	0.560430345930366	0.304814453750654	0.533478012123699	0.0386230219543997
down	GJC1; CAV1; SHH; HAS2; SMO; TMEM100;	GO:0001570~vasculogenesis	6	60	10	0.00024731994806503	0.00501820152686805	0.592083955667703	0.622256989331638	0.319602606307249	0.591836635719638	0.0421922355141077
down	GXYLT2; MUC3A; MUC21; GALNT4; MUC13; A4GNT;	GO:0016266~O-glycan processing	6	60	10	0.00024731994806503	0.00501820152686805	0.592083955667703	0.622256989331638	0.319602606307249	0.591836635719638	0.0421922355141077
down	TBX3; HOXD8; WNT5A;	GO:0008595~anterior/posterior axis specification, embryo	3	7	42.8571428571429	0.00026041251321462	0.00515870390625759	0.622906731609383	0.655197883247997	0.327338529110784	0.622385906582954	0.0433735570393108
down	TGFB2; SIX1; SIX4;	GO:0048699~generation of neurons	3	7	42.8571428571429	0.00026041251321462	0.00515870390625759	0.622906731609383	0.655197883247997	0.327338529110784	0.622385906582954	0.0433735570393108
down	LHX1; OSR1; FOXA2;	GO:2000543~positive regulation of gastrulation	3	7	42.8571428571429	0.00026041251321462	0.00515870390625759	0.622906731609383	0.655197883247997	0.327338529110784	0.622385906582954	0.0433735570393108
down	FGF5; EPCAM; MSX2; HNF4A;	GO:0023019~signal transduction involved in regulation of gene expression	4	20	20	0.00026449634495517	0.00515870390625759	0.631881768097921	0.665472803907229	0.329562445814152	0.631617271752966	0.0433735570393108
down	COL4A1; NR2F2; EFNB2; LAMA1;	GO:0048514~blood vessel morphogenesis	4	20	20	0.00026449634495517	0.00515870390625759	0.631881768097921	0.665472803907229	0.329562445814152	0.631617271752966	0.0433735570393108
down	BCHE; FOSL1; STRA6; SHANK3; PAK5; SHANK2;	GO:0007612~learning	6	62	9.67741935483871	0.00029134263557484	0.00559555779470461	0.69543487111715	0.733018071106304	0.344377869080283	0.695143528481575	0.0470465546357453
down	KLK8; CYP1A1; INHBA; TNC; TGFB2; KLK6;	GO:0009611~response to wounding	6	62	9.67741935483871	0.00029134263557484	0.00559555779470461	0.69543487111715	0.733018071106304	0.344377869080283	0.695143528481575	0.0470465546357453
down	WNT5A; FZD8; FZD10; SFRP1;	GO:0035567~non-canonical Wnt signaling pathway	4	21	19.047619047619	0.00031158023715771	0.00589425471194596	0.743118865621152	0.783935876688813	0.354213849093573	0.742807285383995	0.0495579505237161
down	SHH; SFRP1; DMRTA2; FOXA2;	GO:0071542~dopaminergic neuron differentiation	4	21	19.047619047619	0.00031158023715771	0.00589425471194596	0.743118865621152	0.783935876688813	0.354213849093573	0.742807285383995	0.0495579505237161
down	KRT8; KRT19; FHOD3; SIX4; MYOM3;	GO:0045214~sarcomere organization	5	40	12.5	0.00031971349602089	0.00600297877603403	0.761877261017782	0.80439915598856	0.35778414669445	0.761877261017782	0.0504720850584679
down	CXCL11; GPR37; GPR39; ADCY6; KCNK2; ADGRL2; VIP; CCK; SAA1; PTHLH; ADRA1D; EDNRA; HRH1; ADRA1B; PTGFR; BCAR1; FGD1; GPR176; PLCB4; ARHGEF16; ARHGEF25; OR10A6; SMO; FZD8; ADGRL3; FZD10; APLN; CGB7; GPR87; CCL26; MRGPRX3;	GO:0007186~G protein-coupled receptor signaling pathway	31	1152	2.69097222222222	0.0003252237085547	0.00606120630165649	0.774682873777297	0.818262850723626	0.360347869078608	0.774682873777297	0.0509616527773635
down	MMP2; MSX2; SFRP1;	GO:0060346~bone trabecula formation	3	8	37.5	0.00035453374730742	0.00651099933011306	0.844144852338987	0.89200690822549	0.37355322231413	0.84379031859168	0.0547434405927061
down	SIX1; OSR1; SIX4;	GO:0072075~metanephric mesenchyme development	3	8	37.5	0.00035453374730742	0.00651099933011306	0.844144852338987	0.89200690822549	0.37355322231413	0.84379031859168	0.0547434405927061
down	TBX3; GLI2; SOX9; CAV1;	GO:0030879~mammary gland development	4	22	18.1818181818182	0.00036437802914601	0.00660822582728161	0.866855331338376	0.91677512133138	0.377910049154073	0.866855331338376	0.0555609054244358
down	LRP4; CCK; CSF3; GHR; IL11; CNTN1; CSPG4;	GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation	7	92	7.60869565217391	0.00036508083862962	0.00660822582728161	0.868162234261255	0.918543389992144	0.378223748820294	0.868162234261255	0.0555609054244358
down	TGFB1I1; ISL1; TGFB2; TWIST1; LOXL2;	GO:0010718~positive regulation of epithelial to mesenchymal transition	5	42	11.9047619047619	0.00039274478827788	0.00700812686033451	0.933161616948261	0.988145887307166	0.390781064336498	0.933161616948261	0.0589232093252585
down	FSTL3; KRT75; INHBA; DACT2; SFRP1; BVES;	GO:0002244~hematopoietic progenitor cell differentiation	6	66	9.09090909090909	0.00039769025974645	0.00704639925015546	0.944514366897825	1	0.392917976629495	0.944514366897825	0.0592449974552026
down	DSCAM; TFAP2A; LHX1; FJX1;	GO:0010842~retina layer formation	4	23	17.3913043478261	0.00042327422624466	0.00735957873986145	1	1	0.40413883168668	0.997102327989186	0.0618781604952111
down	KCNU1; KCNK2; LRRC38; NALCN; KCNIP3; KCNS3; KCNA7; KCNF1;	GO:0071805~potassium ion transmembrane transport	8	125	6.4	0.00042414106410171	0.00735957873986145	1	1	0.404445696046727	0.997102327989186	0.0618781604952111
down	GJC1; CDH11; CDH3; CDH18; CDH10;	GO:0007043~cell-cell junction assembly	5	43	11.6279069767442	0.00043365972538833	0.00742236645630648	1	1	0.408216554208638	0.997102327989186	0.0624060695689017
down	CDH3; EFNB2; CDH11; CDH18; CDH10;	GO:0034332~adherens junction organization	5	43	11.6279069767442	0.00043365972538833	0.00742236645630648	1	1	0.408216554208638	0.997102327989186	0.0624060695689017
down	SIX1; SMO; SIX4;	GO:0051451~myoblast migration	3	9	33.3333333333333	0.0004680499942975	0.00785075857101679	1	1	0.422090703001301	0.997102327989186	0.0660079219256613
down	WNT5A; LHX1; FOXA2;	GO:0090009~primitive streak formation	3	9	33.3333333333333	0.0004680499942975	0.00785075857101679	1	1	0.422090703001301	0.997102327989186	0.0660079219256613
down	PCSK9; OSR1; HECW1;	GO:2000650~negative regulation of sodium ion transmembrane transporter activity	3	9	33.3333333333333	0.0004680499942975	0.00785075857101679	1	1	0.422090703001301	0.997102327989186	0.0660079219256613
down	GDNF; ISL1; SHH; SMO; SEMA6D;	GO:0001755~neural crest cell migration	5	44	11.3636363636364	0.00047770522248502	0.0079596446342538	1	1	0.425912451726774	0.997102327989186	0.0669234185233372
down	CXCL11; RBFOX2; PLAU; INHA; SOX9; SHH; FRK; TGFB2; TFAP2A;	GO:0042127~regulation of cell population proliferation	9	163	5.52147239263804	0.00052551154987401	0.00869859907554617	1	1	0.44510828274329	0.997102327989186	0.0731364292313114
down	FGF1; CSF3; FGF5; F3; MST1R; RASD2; MEIS3; C1QTNF1; NOX4;	GO:0051897~positive regulation of protein kinase B signaling	9	165	5.45454545454545	0.00057114331565877	0.00933114663764593	1	1	0.462054942367947	0.997102327989186	0.0784547879243798
down	CXCL14; TGFB2; ROR1; SHH; SIX1;	GO:0048839~inner ear development	5	46	10.8695652173913	0.00057579737629032	0.00934649160481579	1	1	0.463516887913709	0.997102327989186	0.0785838059531139
down	KRT14; CYP1A1; APOD; COL4A2; KRT16; MMP7; NQO1; KRT33B; LOXL2;	GO:0007568~aging	9	166	5.42168674698795	0.00059514646475178	0.00959374061421713	1	1	0.470025754382472	0.997102327989186	0.0806626360637495
down	GLI3; SOX9; SHH;	GO:0030850~prostate gland development	3	10	30	0.00060246860772905	0.00959374061421713	1	1	0.47233538845958	0.997102327989186	0.0806626360637495
down	MMP16; STC1; HMGA2;	GO:0035988~chondrocyte proliferation	3	10	30	0.00060246860772905	0.00959374061421713	1	1	0.47233538845958	0.997102327989186	0.0806626360637495
down	FSTL3; WNT5A; DLX1; SFRP1; HTRA1;	GO:0030514~negative regulation of BMP signaling pathway	5	47	10.6382978723404	0.00063015521855025	0.00990919081170275	1	1	0.481438586972394	0.997102327989186	0.0833148908514507
down	FGF1; FGF5; VEGFC; TGFB2; SHH;	GO:0051781~positive regulation of cell division	5	47	10.6382978723404	0.00063015521855025	0.00990919081170275	1	1	0.481438586972394	0.997102327989186	0.0833148908514507
down	CDH3; CDH18; CDH11; CDH10;	GO:0044331~cell-cell adhesion mediated by cadherin	4	27	14.8148148148148	0.00072765985646994	0.011371380117257	1	1	0.507843010610803	0.997102327989186	0.0956087445788951
down	SOX9; HMGA2; SFRP1;	GO:0010564~regulation of cell cycle process	3	11	27.2727272727273	0.00075922675593875	0.0116476494996458	1	1	0.514282768350671	0.997102327989186	0.0979315733422831
down	TGFB1I1; VEGFC; TBX18;	GO:0016331~morphogenesis of embryonic epithelium	3	11	27.2727272727273	0.00075922675593875	0.0116476494996458	1	1	0.514282768350671	0.997102327989186	0.0979315733422831
down	COL4A1; COL4A6; COL4A2;	GO:0038063~collagen-activated tyrosine kinase receptor signaling pathway	3	11	27.2727272727273	0.00075922675593875	0.0116476494996458	1	1	0.514282768350671	0.997102327989186	0.0979315733422831
down	PIGR; SOX9; BCAR1; EFEMP1; FAM83A;	GO:0007173~epidermal growth factor receptor signaling pathway	5	50	10	0.00081639334125904	0.0123737689554685	1	1	0.525757311770827	0.997102327989186	0.104036669546055
down	SHANK2; SHANK3; ADRA1D; ADRA1B;	GO:0007610~behavior	4	28	14.2857142857143	0.00082293334991434	0.0123982054394281	1	1	0.527020814502848	0.997102327989186	0.104242127593294
down	NKX2-8; CCK; S100A6; SLITRK6; ISL1; MAP1B;	GO:0007409~axonogenesis	6	78	7.69230769230769	0.00090503049641499	0.0135148412461348	1	1	0.541932136867952	0.997102327989186	0.113630622791784
down	COL4A1; EDNRA; SHH; FOXC2;	GO:0001569~branching involved in blood vessel morphogenesis	4	29	13.7931034482759	0.00092667412394353	0.0135148412461348	1	1	0.545811059002744	0.997102327989186	0.113630622791784
down	NCS1; SFRP1; KLK6; MARK1;	GO:0010975~regulation of neuron projection development	4	29	13.7931034482759	0.00092667412394353	0.0135148412461348	1	1	0.545811059002744	0.997102327989186	0.113630622791784
down	CYP1A1; EDNRA; CSPG4; FAM83A; RHBDF1; TP63; PAK5; LIPG;	GO:0008283~cell population proliferation	8	142	5.63380281690141	0.00093590200933801	0.0135148412461348	1	1	0.547427029643325	0.997102327989186	0.113630622791784
down	WNT5A; HNF4A; SMO;	GO:0003323~type B pancreatic cell development	3	12	25	0.00093969336807808	0.0135148412461348	1	1	0.547841233589525	0.997102327989186	0.113630622791784
down	TFAP2A; NQO1; TGFB2; GRIK2; PCSK9;	GO:0043525~positive regulation of neuron apoptotic process	5	52	9.61538461538462	0.000961497832755	0.0135148412461348	1	1	0.551899756001375	0.997102327989186	0.113630622791784
down	CAPN8; UCN2; CYP39A1; CCK;	GO:0007586~digestion	4	30	13.3333333333333	0.00103928166833089	0.0135148412461348	1	1	0.565369227572006	0.997102327989186	0.113630622791784
down	HRH1; CAV1; ADRA1B; ADRA1D;	GO:0045907~positive regulation of vasoconstriction	4	30	13.3333333333333	0.00103928166833089	0.0135148412461348	1	1	0.565369227572006	0.997102327989186	0.113630622791784
down	KCNK2; APOD; DPYSL3; FLRT3;	GO:0048678~response to axon injury	4	30	13.3333333333333	0.00103928166833089	0.0135148412461348	1	1	0.565369227572006	0.997102327989186	0.113630622791784
down	EPCAM; MSX2; HMGA2; OSR1;	GO:0048863~stem cell differentiation	4	30	13.3333333333333	0.00103928166833089	0.0135148412461348	1	1	0.565369227572006	0.997102327989186	0.113630622791784
down	WNT5A; CNTN1; DPYSL3; PLPPR5; TENM3; NDRG4; ROR1;	GO:0010976~positive regulation of neuron projection development	7	111	6.30630630630631	0.00104208235363679	0.0135148412461348	1	1	0.565850718024775	0.997102327989186	0.113630622791784
down	FGF1; WNT5A; BCAR1; CCBE1; FOXC2;	GO:0010595~positive regulation of endothelial cell migration	5	54	9.25925925925926	0.00112492814946585	0.0143345787443355	1	1	0.579944754847291	0.997102327989186	0.120522844516768
down	CDH3; HAS2; TP63;	GO:0010838~positive regulation of keratinocyte proliferation	3	13	23.0769230769231	0.00114517103641154	0.0143345787443355	1	1	0.583286862996005	0.997102327989186	0.120522844516768
down	PLPP2; PLPP4; PLPPR5;	GO:0046839~phospholipid dephosphorylation	3	13	23.0769230769231	0.00114517103641154	0.0143345787443355	1	1	0.583286862996005	0.997102327989186	0.120522844516768
down	DLX1; DLX2; TMEM98;	GO:0048715~negative regulation of oligodendrocyte differentiation	3	13	23.0769230769231	0.00114517103641154	0.0143345787443355	1	1	0.583286862996005	0.997102327989186	0.120522844516768
down	ISL1; TGFB2; SMO;	GO:0060413~atrial septum morphogenesis	3	13	23.0769230769231	0.00114517103641154	0.0143345787443355	1	1	0.583286862996005	0.997102327989186	0.120522844516768
down	WNT5A; SFRP1; VANGL2;	GO:0090179~planar cell polarity pathway involved in neural tube closure	3	13	23.0769230769231	0.00114517103641154	0.0143345787443355	1	1	0.583286862996005	0.997102327989186	0.120522844516768
down	EPCAM; ADGRL3; FLRT3;	GO:0098742~cell-cell adhesion via plasma-membrane adhesion molecules	3	13	23.0769230769231	0.00114517103641154	0.0143345787443355	1	1	0.583286862996005	0.997102327989186	0.120522844516768
down	GLI2; LHX1; SHH; SIX1;	GO:0007389~pattern specification process	4	31	12.9032258064516	0.0011611553512263	0.0144627072459671	1	1	0.586122658181746	0.997102327989186	0.121600128457631
down	TFPI2; SPOCK1; WFDC2; SERPINB7; SERPINE2; SERPINB5; SERPINA10; SERPINH1;	GO:0010951~negative regulation of endopeptidase activity	8	148	5.40540540540541	0.00120449459232197	0.0149286127797147	1	1	0.592939220339656	0.997102327989186	0.125517387639423
down	HNF4A; CAV1; MALL; PCSK9; LIPG; CYP39A1;	GO:0042632~cholesterol homeostasis	6	83	7.2289156626506	0.00122380488475204	0.0150935935786085	1	1	0.595992978874246	0.997102327989186	0.126904519799215
down	CCBE1; PARVA; LOXL2; VEGFC;	GO:0002040~sprouting angiogenesis	4	32	12.5	0.00129269392564857	0.0158654532533259	1	1	0.606273451129179	0.997102327989186	0.133394192444913
down	WNT5A; TP63; VANGL2;	GO:0001736~establishment of planar polarity	3	14	21.4285714285714	0.00137689787564832	0.016575478732685	1	1	0.616247740411445	0.997102327989186	0.139363973069653
down	SHH; SMO; STRA6;	GO:0048745~smooth muscle tissue development	3	14	21.4285714285714	0.00137689787564832	0.016575478732685	1	1	0.616247740411445	0.997102327989186	0.139363973069653
down	NOS1; STC1; PACSIN3;	GO:0051926~negative regulation of calcium ion transport	3	14	21.4285714285714	0.00137689787564832	0.016575478732685	1	1	0.616247740411445	0.997102327989186	0.139363973069653
down	TGFB2; FOXC2; NDRG4;	GO:0060038~cardiac muscle cell proliferation	3	14	21.4285714285714	0.00137689787564832	0.016575478732685	1	1	0.616247740411445	0.997102327989186	0.139363973069653
down	PLPP2; PLPP4; PCSK9; GATA6; PLPPR5;	GO:0006644~phospholipid metabolic process	5	57	8.7719298245614	0.00140745199016434	0.0167826976647085	1	1	0.619409026353879	0.997102327989186	0.1411062366946
down	KCNK2; FOSL1; TNC; MAP1B; POSTN;	GO:0009612~response to mechanical stimulus	5	57	8.7719298245614	0.00140745199016434	0.0167826976647085	1	1	0.619409026353879	0.997102327989186	0.1411062366946
down	SOX9; CRNN; CDH10; CDH11; CDH3; COL16A1; DSG2; CDH18;	GO:0098609~cell-cell adhesion	8	152	5.26315789473684	0.00141532218468043	0.0167969368710187	1	1	0.620336884305814	0.997102327989186	0.141225957662951
up	TYROBP; CTLA4; IL10; FCGR2B; MNDA; CD300A; TNFRSF13B;	GO:0030889~negative regulation of B cell proliferation	7	16	43.75	0.00155472329282813	0.235256341366418	1	1	0.999999999999997	0.999999999999997	1
up	F13A1; CSTA; ANXA1; DSP; TGM1; EVPL; TGM4; TGM5; EPB42;	GO:0018149~peptide cross-linking	9	27	33.3333333333333	0.0016265366153555	0.235256341366418	1	1	0.999999999999997	0.999999999999997	1
down	CYP1A1; APOD; INHBA; CDH3; MAP1B; VEGFC; TGFB2; SFRP1; GATA6;	GO:0042493~response to drug	9	193	4.66321243523316	0.00162807935182707	0.0177243570278215	1	1	0.642434388524924	0.997102327989186	0.149023557951988
down	TBX2; FOXC2; NDRG4;	GO:0035050~embryonic heart tube development	3	15	20	0.00163604934007222	0.0177243570278215	1	1	0.642967390648383	0.997102327989186	0.149023557951988
down	KRT14; KRT16; KRT33B;	GO:0042633~hair cycle	3	15	20	0.00163604934007222	0.0177243570278215	1	1	0.642967390648383	0.997102327989186	0.149023557951988
down	SERPINB5; SIX1; SIX4;	GO:0050678~regulation of epithelial cell proliferation	3	15	20	0.00163604934007222	0.0177243570278215	1	1	0.642967390648383	0.997102327989186	0.149023557951988
down	GLI3; SHANK3; SHANK2;	GO:0071625~vocalization behavior	3	15	20	0.00163604934007222	0.0177243570278215	1	1	0.642967390648383	0.997102327989186	0.149023557951988
down	HRH1; ANO1; ADRA1D; VIP; ADRA1B;	GO:0007200~phospholipase C-activating G protein-coupled receptor signaling pathway	5	60	8.33333333333333	0.00173905314116474	0.0179322037015184	1	1	0.651680453072794	0.997102327989186	0.150771099528485
down	ADCY6; EFNB2; SPOCK1; CRMP1; DPYSL3;	GO:0010977~negative regulation of neuron projection development	5	61	8.19672131147541	0.0018613263538465	0.01911468206644	1	1	0.661719037439054	0.997102327989186	0.160713188421485
down	WNT9A; SHH; SFRP1; SMO;	GO:0045880~positive regulation of smoothened signaling pathway	4	36	11.1111111111111	0.00192342487036656	0.0192833858155719	1	1	0.666978487142907	0.997102327989186	0.162131622551197
down	WNT5A; APLN; SPRY4;	GO:0040037~negative regulation of fibroblast growth factor receptor signaling pathway	3	16	18.75	0.00192373999988416	0.0192833858155719	1	1	0.666978487142907	0.997102327989186	0.162131622551197
down	WNT5A; KLK6; KLK5;	GO:0045745~positive regulation of G protein-coupled receptor signaling pathway	3	16	18.75	0.00192373999988416	0.0192833858155719	1	1	0.666978487142907	0.997102327989186	0.162131622551197
down	ISL1; SIX1; DMRTA2;	GO:0048665~neuron fate specification	3	16	18.75	0.00192373999988416	0.0192833858155719	1	1	0.666978487142907	0.997102327989186	0.162131622551197
down	SAA1; KRT20; RHBDF1;	GO:0050708~regulation of protein secretion	3	16	18.75	0.00192373999988416	0.0192833858155719	1	1	0.666978487142907	0.997102327989186	0.162131622551197
down	DSCAM; VSTM2L; PALLD;	GO:0070593~dendrite self-avoidance	3	16	18.75	0.00192373999988416	0.0192833858155719	1	1	0.666978487142907	0.997102327989186	0.162131622551197
down	THBS2; TPBG; SLITRK6; ADGRL3; FLRT3;	GO:0051965~positive regulation of synapse assembly	5	62	8.06451612903226	0.001989770091123	0.01986611725899	1	1	0.672542290799574	0.997102327989186	0.167031135289084
up	TGM5; PPL; CSTA; KRT3; DSP; TGM1; DSG3; DSG1; DSC2; PKP1; LIPN; KRT79; KRT80; KRT73; CERS3; KRT78; EVPL; PERP; TMEM79; SPINK5; PKP3;	GO:0070268~cornification	21	113	18.5840707964602	0.00207153560340512	0.28659244739283	1	1	0.999999999999997	0.999999999999997	1
down	GLI2; SOX9; HMGA2; OSR1;	GO:0002062~chondrocyte differentiation	4	37	10.8108108108108	0.00210921586150903	0.0209754431128724	1	1	0.682203975704685	0.997102327989186	0.176358169573837
down	AKR1B10; RBP1; SDC1; STRA6; GPC6;	GO:0001523~retinoid metabolic process	5	63	7.93650793650794	0.00212456592107568	0.0210449128245135	1	1	0.68366642030367	0.997102327989186	0.176942259794001
down	KRT16; SERPINB5; SOX9;	GO:0002009~morphogenesis of an epithelium	3	17	17.6470588235294	0.00224102527647452	0.0221114493945486	1	1	0.692758496945259	0.997102327989186	0.185909528626549
down	GLI3; DLX1; DLX2; CDK5R2; LHX5;	GO:0021766~hippocampus development	5	64	7.8125	0.00226589598981097	0.022269509024861	1	1	0.695121180464754	0.997102327989186	0.187238468708311
down	TERT; SLIT3; ROS1; XDH; TGFB2; NR0B2; SFRP1; SMO; APLN;	GO:0010629~negative regulation of gene expression	9	204	4.41176470588235	0.00233221241012282	0.0228320872524087	1	1	0.700038983265513	0.997102327989186	0.19196853643172
down	APOD; PLTP; ABCA12; SLCO2A1; CAV1;	GO:0006869~lipid transport	5	65	7.69230769230769	0.00241394291275188	0.0234497311524468	1	1	0.707027034819643	0.997102327989186	0.197161587518795
down	GLI2; GLI3; SHH; DZIP1; SMO;	GO:0007224~smoothened signaling pathway	5	65	7.69230769230769	0.00241394291275188	0.0234497311524468	1	1	0.707027034819643	0.997102327989186	0.197161587518795
down	KRT20; KRT17; SHH;	GO:0045109~intermediate filament organization	3	18	16.6666666666667	0.00258890313897797	0.0236002909335818	1	1	0.720608084762154	0.997102327989186	0.198427470068666
down	GLI3; SHROOM2; TENM3;	GO:0048593~camera-type eye morphogenesis	3	18	16.6666666666667	0.00258890313897797	0.0236002909335818	1	1	0.720608084762154	0.997102327989186	0.198427470068666
down	ISL1; SIX1; SIX4;	GO:0060037~pharyngeal system development	3	18	16.6666666666667	0.00258890313897797	0.0236002909335818	1	1	0.720608084762154	0.997102327989186	0.198427470068666
down	S100A6; GJC1; SCNN1G; GRIK2; FXYD3; ANO4; ANO1; TMC7; NALCN;	GO:0034220~ion transmembrane transport	9	208	4.32692307692308	0.00264122547089973	0.0239903367681723	1	1	0.724846566282674	0.997102327989186	0.201706913037671
up	HP; ANXA3; IL10; DEFB1; S100A12; IRF8; S100A14; STAB1; IGHG2; IGLC3; IGHG3; IGHV1-46; TRBC1; IGHV1-2; TRBC2; IGHV3-30; IGHA2; IGLC2; IGHV2-5; IGHD; IGHV3-74; IGHV1-18; IGHV3-7; GSDMC; IGHV4-34; IGHV5-51; IGHV3-35; IGHV3-23; TRDC; IGKC; IGHV4-39; IGHV3-21; IGHG4;	GO:0042742~defense response to bacterium	33	216	15.2777777777778	0.00266083051863397	0.352781779595554	1	1	0.999999999999997	0.999999999999997	1
down	ADCY6; EDNRA; CAP2; LGR4;	GO:0007190~activation of adenylate cyclase activity	4	40	10	0.00274023208087715	0.0248000860269313	1	1	0.732652984434253	0.997102327989186	0.208515155243571
down	P4HA2; XDH; AOX1; NOX4; LOXL2;	GO:0022900~electron transport chain	5	68	7.35294117647059	0.00290021570317878	0.0261539165204222	1	1	0.744583556029416	0.997102327989186	0.219897945416847
down	DLX2; DLX1; OSR1;	GO:0009790~embryo development	3	19	15.7894736842105	0.00296831576126277	0.0262967692089336	1	1	0.749283478172966	0.997102327989186	0.221099027965091
down	PLTP; CAV1; ABCA12;	GO:0010875~positive regulation of cholesterol efflux	3	19	15.7894736842105	0.00296831576126277	0.0262967692089336	1	1	0.749283478172966	0.997102327989186	0.221099027965091
down	LRP4; SOX9; SFRP1;	GO:0030279~negative regulation of ossification	3	19	15.7894736842105	0.00296831576126277	0.0262967692089336	1	1	0.749283478172966	0.997102327989186	0.221099027965091
down	TBX3; SHH; LGR4;	GO:0030539~male genitalia development	3	19	15.7894736842105	0.00296831576126277	0.0262967692089336	1	1	0.749283478172966	0.997102327989186	0.221099027965091
down	GLI3; SOX9; LOXL2;	GO:0032332~positive regulation of chondrocyte differentiation	3	19	15.7894736842105	0.00296831576126277	0.0262967692089336	1	1	0.749283478172966	0.997102327989186	0.221099027965091
down	ROS1; BCAR1; SPOCK1; PAPPA2; PAK5;	GO:0001558~regulation of cell growth	5	69	7.2463768115942	0.00307696177245365	0.0271636344543627	1	1	0.756717318301274	0.997102327989186	0.228387492248224
down	FOSL1; TGFB2; CAV1; DSG2;	GO:0032570~response to progesterone	4	42	9.52380952380952	0.00322605345527927	0.0282813606044691	1	1	0.765198280391464	0.997102327989186	0.237785154879561
down	TERT; CSF3; WNT5A; CAV1; PLK2;	GO:0032092~positive regulation of protein binding	5	70	7.14285714285714	0.00326134102560471	0.0284914375709078	1	1	0.767439677515299	0.997102327989186	0.23955144840058
down	NKX3-2; SIX1; OSR1;	GO:0042474~middle ear morphogenesis	3	20	15	0.00338015114138046	0.0290406859735679	1	1	0.774482173803801	0.997102327989186	0.244169441089136
down	EPCAM; TWIST1; DUOXA2;	GO:2000147~positive regulation of cell motility	3	20	15	0.00338015114138046	0.0290406859735679	1	1	0.774482173803801	0.997102327989186	0.244169441089136
down	AKR1B15; AKR1B10; CYP1A1; CYP27C1;	GO:0042572~retinol metabolic process	4	44	9.09090909090909	0.00376743135478153	0.0306759135554379	1	1	0.797799696246766	0.997102327989186	0.257918172957321
down	VEGFC; TWIST1; SFRP1; TWIST2;	GO:0045668~negative regulation of osteoblast differentiation	4	44	9.09090909090909	0.00376743135478153	0.0306759135554379	1	1	0.797799696246766	0.997102327989186	0.257918172957321
down	IL33; KRT8; INHBA; TGFB2;	GO:0097191~extrinsic apoptotic signaling pathway	4	44	9.09090909090909	0.00376743135478153	0.0306759135554379	1	1	0.797799696246766	0.997102327989186	0.257918172957321
down	EDNRA; SOX9; FOXC2;	GO:0014032~neural crest cell development	3	21	14.2857142857143	0.0038252446837429	0.0308471654624908	1	1	0.799852354127332	0.997102327989186	0.259358031591123
down	CLDN14; CLDN12; CLDN18;	GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules	3	21	14.2857142857143	0.0038252446837429	0.0308471654624908	1	1	0.799852354127332	0.997102327989186	0.259358031591123
down	SHANK2; SHANK3; SHISA9;	GO:2000311~regulation of AMPA receptor activity	3	21	14.2857142857143	0.0038252446837429	0.0308471654624908	1	1	0.799852354127332	0.997102327989186	0.259358031591123
down	F3; WNT5A; CCL26; VEGFC; VIP;	GO:0001938~positive regulation of endothelial cell proliferation	5	73	6.84931506849315	0.00386210824576949	0.0310449340139171	1	1	0.801955383980428	0.997102327989186	0.261020837928091
down	TNC; MSX2; TWIST1; SFRP1; SMO; LGR4;	GO:0001649~osteoblast differentiation	6	106	5.66037735849057	0.00390447966479956	0.0312855759128526	1	1	0.80411066302242	0.997102327989186	0.263044116511083
down	TFAP2A; COL11A1; ALDH7A1; ROR1; SIX1; SLITRK6; SLC52A3;	GO:0007605~sensory perception of sound	7	143	4.89510489510489	0.00405095932338817	0.0322226695961082	1	1	0.810191864677634	0.997102327989186	0.270923050262749
down	MUC21; DSCAM; TNC; DACT2;	GO:0007162~negative regulation of cell adhesion	4	45	8.88888888888889	0.0040598514554715	0.0322226695961082	1	1	0.810910220774254	0.997102327989186	0.270923050262749
down	SERPINE2; PLK2; SHANK2; SHANK3;	GO:0060291~long-term synaptic potentiation	4	45	8.88888888888889	0.0040598514554715	0.0322226695961082	1	1	0.810910220774254	0.997102327989186	0.270923050262749
down	VIP; WNT5A; SOX9; PLK2; HECW1;	GO:0045732~positive regulation of protein catabolic process	5	74	6.75675675675676	0.00407884885580345	0.0322716469220172	1	1	0.811690922304887	0.997102327989186	0.271334843782507
up	CCL24; LGALS3; CCL7; XCL1; XCL2; CCL8; CCL2;	GO:0048245~eosinophil chemotaxis	7	20	35	0.00425267552522024	0.541280540850032	1	1	0.999999999999997	0.999999999999997	1
down	LHX1; SIM2; SHH;	GO:0009880~embryonic pattern specification	3	22	13.6363636363636	0.00430438074466455	0.033843193604925	1	1	0.817591029457651	0.997102327989186	0.284548156841308
down	ITGB6; FBN1; COL16A1;	GO:0033627~cell adhesion mediated by integrin	3	22	13.6363636363636	0.00430438074466455	0.033843193604925	1	1	0.817591029457651	0.997102327989186	0.284548156841308
down	WNT5A; FOXC2; HES7; TBX18;	GO:0001756~somitogenesis	4	46	8.69565217391304	0.00436722697377423	0.0341240467888694	1	1	0.818972274861543	0.997102327989186	0.286909525474757
down	TBX3; ISL1; TBX2; SIX1;	GO:0003151~outflow tract morphogenesis	4	46	8.69565217391304	0.00436722697377423	0.0341240467888694	1	1	0.818972274861543	0.997102327989186	0.286909525474757
down	GLI2; TGFB2; DPYSL3; TENM3;	GO:0048666~neuron development	4	47	8.51063829787234	0.00468990183323359	0.035328721594059	1	1	0.827223158002673	0.997102327989186	0.297038238486048
down	ZNF423; FOXC2; LGR4; HOXC10;	GO:0120163~negative regulation of cold-induced thermogenesis	4	47	8.51063829787234	0.00468990183323359	0.035328721594059	1	1	0.827223158002673	0.997102327989186	0.297038238486048
down	WNT5A; SOX9; SMO;	GO:0002053~positive regulation of mesenchymal cell proliferation	3	23	13.0434782608696	0.00481829414235047	0.0360616168829961	1	1	0.830529634363497	0.997102327989186	0.303200304810497
down	GLI2; GLI3; STRA6;	GO:0048589~developmental growth	3	23	13.0434782608696	0.00481829414235047	0.0360616168829961	1	1	0.830529634363497	0.997102327989186	0.303200304810497
down	TERT; KCNK2; STC1; TWIST1; SFRP1; GATA6;	GO:0071456~cellular response to hypoxia	6	111	5.40540540540541	0.00483019272240448	0.0360616168829961	1	1	0.830793148253571	0.997102327989186	0.303200304810497
down	NTF4; GDNF; SLITRK6; FOXA2;	GO:0008344~adult locomotory behavior	4	48	8.33333333333333	0.00502821405114462	0.0374289542978694	1	1	0.835841101709076	0.997102327989186	0.314696659017617
down	ISL1; NKX3-2; SHH;	GO:0031016~pancreas development	3	24	12.5	0.00536767163177476	0.0393733580919688	1	1	0.844713666479531	0.997102327989186	0.331044895009321
down	ONECUT2; SOX9; FOXA2;	GO:0031018~endocrine pancreas development	3	24	12.5	0.00536767163177476	0.0393733580919688	1	1	0.844713666479531	0.997102327989186	0.331044895009321
down	TBX3; CXCL14; SOX9;	GO:0045662~negative regulation of myoblast differentiation	3	24	12.5	0.00536767163177476	0.0393733580919688	1	1	0.844713666479531	0.997102327989186	0.331044895009321
down	FSTL3; FBN1; SFRP1;	GO:0045671~negative regulation of osteoclast differentiation	3	24	12.5	0.00536767163177476	0.0393733580919688	1	1	0.844713666479531	0.997102327989186	0.331044895009321
down	VIP; GDNF; RBM24;	GO:0048255~mRNA stabilization	3	24	12.5	0.00536767163177476	0.0393733580919688	1	1	0.844713666479531	0.997102327989186	0.331044895009321
up	APOA2; IL10; ANGPT1; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	4	6	66.6666666666667	0.0056415025125085	0.641116464100073	1	1	0.999999999999997	0.999999999999997	1
down	KCNU1; NALCN; KCNA7; KCNS3; KCNF1; KCNJ5;	GO:0034765~regulation of ion transmembrane transport	6	115	5.21739130434783	0.00567946359508542	0.0403723283495873	1	1	0.852497863304811	0.997102327989186	0.339444077097836
down	SOX9; SFRP1; HAS2; ADAMTS7; CCL26;	GO:0071347~cellular response to interleukin-1	5	81	6.17283950617284	0.00584537538096896	0.0403723283495873	1	1	0.857350349637453	0.997102327989186	0.339444077097836
down	WNT9A; TGFB1I1; LRP4; WNT5A; WNT7B; NXN; FERMT2; MARK1;	GO:0016055~Wnt signaling pathway	8	194	4.12371134020619	0.00587067809975028	0.0403723283495873	1	1	0.857350349637453	0.997102327989186	0.339444077097836
down	KRT16; STC1; DPYSL3; SHH; SFRP1; DLC1;	GO:0030336~negative regulation of cell migration	6	116	5.17241379310345	0.00590778057287955	0.0403723283495873	1	1	0.858614017953245	0.997102327989186	0.339444077097836
down	TBX3; TBX2; NOX4;	GO:0007569~cell aging	3	25	12	0.00595315334566648	0.0403723283495873	1	1	0.859898924391992	0.997102327989186	0.339444077097836
down	COL11A1; ISL1; FOXC2;	GO:0055010~ventricular cardiac muscle tissue morphogenesis	3	25	12	0.00595315334566648	0.0403723283495873	1	1	0.859898924391992	0.997102327989186	0.339444077097836
down	COL4A1; COL5A2; MMP2; COL16A1;	GO:0071230~cellular response to amino acid stimulus	4	51	7.84313725490196	0.00614026241929522	0.0415293017391042	1	1	0.865262012136326	0.997102327989186	0.349171724238488
down	CRMP1; MARK1; MAP1B; TUBB3; TUBAL3; CALML3;	GO:0000226~microtubule cytoskeleton organization	6	118	5.08474576271187	0.00638436928448149	0.0430645391950548	1	1	0.871011628727098	0.997102327989186	0.362079755126592
down	NR2F2; HNF4A; HNF4G; NR0B2;	GO:0043401~steroid hormone mediated signaling pathway	4	52	7.69230769230769	0.00654437953993292	0.0440258259959124	1	1	0.875603336421118	0.997102327989186	0.370162100740101
down	FRK; BCAR1; NTF4; MST1R; ROR1; ROS1;	GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway	6	120	5	0.00688828099718408	0.0462157733037737	1	1	0.883850578395813	0.997102327989186	0.388574827307988
down	IL33; WNT5A; ISL1; RAB7B;	GO:0032755~positive regulation of interleukin-6 production	4	53	7.54716981132075	0.00696572910275017	0.0466111021875517	1	1	0.885597053166925	0.997102327989186	0.391898689309261
down	ARTN; NTF4; GDNF;	GO:0007422~peripheral nervous system development	3	27	11.1111111111111	0.00723476527335509	0.0476762879954183	1	1	0.892939375674049	0.997102327989186	0.400854601149622
down	LHX1; POSTN; SFRP1;	GO:0044344~cellular response to fibroblast growth factor stimulus	3	27	11.1111111111111	0.00723476527335509	0.0476762879954183	1	1	0.892939375674049	0.997102327989186	0.400854601149622
down	VEGFC; APLN; NOS1;	GO:0045776~negative regulation of blood pressure	3	27	11.1111111111111	0.00723476527335509	0.0476762879954183	1	1	0.892939375674049	0.997102327989186	0.400854601149622
down	SERPINE2; GLI2; GLI3;	GO:0045879~negative regulation of smoothened signaling pathway	3	27	11.1111111111111	0.00723476527335509	0.0476762879954183	1	1	0.892939375674049	0.997102327989186	0.400854601149622
up	CCL21; TRPM2; CXCR1; CCR2; CCR5; CCR6;	GO:0002407~dendritic cell chemotaxis	6	17	35.2941176470588	0.00774394214917795	0.849697376506353	1	1	0.999999999999997	0.999999999999997	1
down	GLI3; F3; MMP16; KLK13;	GO:0016485~protein processing	4	55	7.27272727272727	0.00786131414641855	0.0507155548522797	1	1	0.909581973356863	0.997102327989186	0.426408270592417
down	SLIT3; SOX9; TWIST1;	GO:0003180~aortic valve morphogenesis	3	28	10.7142857142857	0.00793195513943357	0.0509102018643236	1	1	0.911872667981744	0.997102327989186	0.428044831525713
down	CYP1A1; CLDN18; LGR4;	GO:0048565~digestive tract development	3	28	10.7142857142857	0.00793195513943357	0.0509102018643236	1	1	0.911872667981744	0.997102327989186	0.428044831525713
down	SLIT3; SERPINE2; INHBA; HNF4A; TGFB2; SFRP1;	GO:0030308~negative regulation of cell growth	6	124	4.83870967741935	0.00798149217088662	0.0510977972059815	1	1	0.911872667981744	0.997102327989186	0.429622103142686
down	CSF3; IL11; NOS1; WNT5A; CAV1;	GO:0033138~positive regulation of peptidyl-serine phosphorylation	5	88	5.68181818181818	0.00809148880254229	0.0516705224040518	1	1	0.914338234687279	0.997102327989186	0.43443748497071
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.00832989292665953	0.883523976421021	1	1	0.999999999999997	0.999999999999997	1
down	PDLIM4; SYDE1; ANTXR1; PARVA;	GO:0031532~actin cytoskeleton reorganization	4	56	7.14285714285714	0.00833612625412705	0.0530979586212245	1	1	0.921574433451831	0.997102327989186	0.446439140291617
down	PTHLH; TSPAN8; GDNF; LHX1; CRNN; SHH; ZNF462;	GO:0010468~regulation of gene expression	7	166	4.21686746987952	0.00866062437859005	0.0547917233809132	1	1	0.929471907172908	0.997102327989186	0.460680043384818
up	TRPM2; GATA1; FLT3; LILRB1; BATF3;	GO:0097028~dendritic cell differentiation	5	12	41.6666666666667	0.00866330898616907	0.889246748193225	1	1	0.999999999999997	0.999999999999997	1
down	GLI3; SHH; FZD8;	GO:0033077~T cell differentiation in thymus	3	29	10.3448275862069	0.00866737118664684	0.0547917233809132	1	1	0.929471907172908	0.997102327989186	0.460680043384818
down	GLI3; SOX9; SHH;	GO:0048709~oligodendrocyte differentiation	3	29	10.3448275862069	0.00866737118664684	0.0547917233809132	1	1	0.929471907172908	0.997102327989186	0.460680043384818
down	TFAP2A; COL11A1; SIX1; SIX4;	GO:0042472~inner ear morphogenesis	4	57	7.01754385964912	0.00882932383873536	0.0552068857536749	1	1	0.935065951058671	0.997102327989186	0.464170662188063
down	RNF180; SHANK3; SHANK2;	GO:0030534~adult behavior	3	30	10	0.00944144089295218	0.0575173493623915	1	1	0.944144089295218	0.997102327989186	0.483596670530655
down	HMGA2; ZNF462; SMO;	GO:0043392~negative regulation of DNA binding	3	30	10	0.00944144089295218	0.0575173493623915	1	1	0.944144089295218	0.997102327989186	0.483596670530655
down	BCAR1; CSPG4; PLAT;	GO:0048008~platelet-derived growth factor receptor signaling pathway	3	30	10	0.00944144089295218	0.0575173493623915	1	1	0.944144089295218	0.997102327989186	0.483596670530655
down	APOD; NDRG4; VIP;	GO:0048662~negative regulation of smooth muscle cell proliferation	3	30	10	0.00944144089295218	0.0575173493623915	1	1	0.944144089295218	0.997102327989186	0.483596670530655
down	TFAP2A; HAS2; PAPPA2;	GO:0060349~bone morphogenesis	3	30	10	0.00944144089295218	0.0575173493623915	1	1	0.944144089295218	0.997102327989186	0.483596670530655
down	TERT; IL11; ANGPTL4;	GO:2000352~negative regulation of endothelial cell apoptotic process	3	30	10	0.00944144089295218	0.0575173493623915	1	1	0.944144089295218	0.997102327989186	0.483596670530655
up	CES2; PTGES; HPGDS; HPGD; AKR1C2; AKR1C4;	GO:0006693~prostaglandin metabolic process	6	18	33.3333333333333	0.009643340844118	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
down	APOD; NR2F2; HNF4A; PLTP; ANGPTL4; LIPG;	GO:0006629~lipid metabolic process	6	130	4.61538461538462	0.00984743020677314	0.0595631245087446	1	1	0.947960847451454	0.997102327989186	0.500797220632457
down	GPR37; ADCY6; EDNRA; GPR176;	GO:0007193~adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway	4	59	6.77966101694915	0.00987194869640162	0.0595631245087446	1	1	0.947960847451454	0.997102327989186	0.500797220632457
down	HNF4A; TGFB2; INHA; INHBA;	GO:0060395~SMAD protein signal transduction	4	59	6.77966101694915	0.00987194869640162	0.0595631245087446	1	1	0.947960847451454	0.997102327989186	0.500797220632457
down	NOS1; MAP1B; TWIST1; SFRP1;	GO:0071363~cellular response to growth factor stimulus	4	59	6.77966101694915	0.00987194869640162	0.0595631245087446	1	1	0.947960847451454	0.997102327989186	0.500797220632457
up	CCL24; CCL21; CCL22; EREG; SIGLEC6; FGF18; POMC; GHRH; WNT1; EDN3; GATA1; TRH; FGFR3; SSTR3; XCL1; FASLG; CCR5; EFNA3; CCL8; CCL7; CRB1; PCDH1; GRAP; IL18; LILRB2; FCRL2; IL26; STAB1; SIRPG; ADRB2; FGFBP1; FGFBP2;	GO:0007267~cell-cell signaling	32	230	13.9130434782609	0.0101554811007626	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
down	NR2F2; XDH; CAV1;	GO:0001937~negative regulation of endothelial cell proliferation	3	31	9.67741935483871	0.0102545530760048	0.0608827340432389	1	1	0.952670626845078	0.997102327989186	0.511892286457922
down	S100A2; LOXL2; TGFB1I1;	GO:0043542~endothelial cell migration	3	31	9.67741935483871	0.0102545530760048	0.0608827340432389	1	1	0.952670626845078	0.997102327989186	0.511892286457922
down	GLI3; MSX2; WNT7B; TP63;	GO:0045669~positive regulation of osteoblast differentiation	4	60	6.66666666666667	0.0104218939710055	0.0608827340432389	1	1	0.953919867111069	0.997102327989186	0.511892286457922
down	CTSV; BCHE; SDC1; WNT7B;	GO:0051384~response to glucocorticoid	4	60	6.66666666666667	0.0104218939710055	0.0608827340432389	1	1	0.953919867111069	0.997102327989186	0.511892286457922
up	ACOD1; CCL21; NCR3; IL18RAP; LY86; CALCA; ORM1; ANXA1; CCL2; FOLR2; SELE; CD40LG; FCGR2B; CNR2; IL13; BDKRB1; CXCR3; AIF1; NLRP6; ELF3; S100A12; MS4A2; FUT7; NAIP; IL18; NLRP9; IL17RE; PLD4; CD180; MGLL; IL22; PROK2; IL23A; STAB1; PF4; PTGDR; CCL8; CCL24; PF4V1; CCL7; CCR5; CCL22; XCL1; IL1RN; FPR3; CCR2; XCL2; IL2RA;	GO:0006954~inflammatory response	48	381	12.5984251968504	0.0105254132015545	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
down	COL4A1; APOD; DLX2; SHROOM2; CTTNBP2; NDRG4; ADGRL3; ADGRL2;	GO:0007420~brain development	8	217	3.68663594470046	0.0108729054472603	0.0621732502393337	1	1	0.957857345924131	0.997102327989186	0.522742740149124
down	MAP1B; CAPN6; NCKAP5;	GO:0001578~microtubule bundle formation	3	32	9.375	0.0111070591126919	0.0629400016385877	1	1	0.960652785427776	0.997102327989186	0.529189463232062
down	SLC6A15; SLC6A14; SLC6A5;	GO:0006810~transport	3	32	9.375	0.0111070591126919	0.0629400016385877	1	1	0.960652785427776	0.997102327989186	0.529189463232062
down	LRP4; LHX1; SHH;	GO:0009953~dorsal/ventral pattern formation	3	32	9.375	0.0111070591126919	0.0629400016385877	1	1	0.960652785427776	0.997102327989186	0.529189463232062
down	TGFB2; LTBP2; FERMT2; CGN; TGFB1I1;	GO:0007179~transforming growth factor beta receptor signaling pathway	5	96	5.20833333333333	0.0113199081925457	0.0638584955435986	1	1	0.962192196366384	0.997102327989186	0.536912013024254
down	BCAR1; COL16A1; DOCK1; FERMT2; ITGB6;	GO:0007229~integrin-mediated signaling pathway	5	96	5.20833333333333	0.0113199081925457	0.0638584955435986	1	1	0.962192196366384	0.997102327989186	0.536912013024254
down	KRT19; GLI3; CAV1; GATA6;	GO:0043627~response to estrogen	4	62	6.45161290322581	0.0115802885976424	0.0650357279278308	1	1	0.96512926625456	0.997102327989186	0.546809994550987
down	KLK8; WNT7B; NYAP1; NTF4;	GO:0048812~neuron projection morphogenesis	4	62	6.45161290322581	0.0115802885976424	0.0650357279278308	1	1	0.96512926625456	0.997102327989186	0.546809994550987
up	LTF; RNASE7; DEFA4; DEFA3;	GO:0051673~membrane disruption in other organism	4	8	50	0.011693334327972	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
down	HOXD8; HOXC8; NKX3-2;	GO:0048705~skeletal system morphogenesis	3	33	9.09090909090909	0.011999274129687	0.0670892749117613	1	1	0.969984041235719	0.997102327989186	0.564075889019629
down	NOS1; HES7; HES2;	GO:0050767~regulation of neurogenesis	3	33	9.09090909090909	0.011999274129687	0.0670892749117613	1	1	0.969984041235719	0.997102327989186	0.564075889019629
down	VEGFC; BCAR1; DOCK1; FOXC2;	GO:0048010~vascular endothelial growth factor receptor signaling pathway	4	64	6.25	0.0128182506881666	0.0692246788595268	1	1	0.97680886798355	0.997102327989186	0.582030023742892
down	COL4A1; TNC; PPFIBP1;	GO:0007528~neuromuscular junction development	3	34	8.82352941176471	0.0129314781653329	0.0692246788595268	1	1	0.978095836189062	0.997102327989186	0.582030023742892
down	MSX2; FOXD1; ZNF423;	GO:0030513~positive regulation of BMP signaling pathway	3	34	8.82352941176471	0.0129314781653329	0.0692246788595268	1	1	0.978095836189062	0.997102327989186	0.582030023742892
down	FZD8; VANGL2; FZD10;	GO:0043507~positive regulation of JUN kinase activity	3	34	8.82352941176471	0.0129314781653329	0.0692246788595268	1	1	0.978095836189062	0.997102327989186	0.582030023742892
down	RBFOX2; DSCAM; LRP4;	GO:0048813~dendrite morphogenesis	3	34	8.82352941176471	0.0129314781653329	0.0692246788595268	1	1	0.978095836189062	0.997102327989186	0.582030023742892
down	TBX3; SLIT3; TGFB2;	GO:0060412~ventricular septum morphogenesis	3	34	8.82352941176471	0.0129314781653329	0.0692246788595268	1	1	0.978095836189062	0.997102327989186	0.582030023742892
up	CCR6; SPNS2; TBX21;	GO:0072676~lymphocyte migration	3	4	75	0.013720807019042	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
up	TJP1; ANGPT1; OCLN;	GO:1905605~positive regulation of maintenance of permeability of blood-brain barrier	3	4	75	0.013720807019042	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
down	SOX9; TGFB2; DOCK1;	GO:0010634~positive regulation of epithelial cell migration	3	35	8.57142857142857	0.0139039173042954	0.0736009678602863	1	1	0.985133943562955	0.997102327989186	0.618825161444961
down	TBX3; FOSL1; TGFB2;	GO:0045787~positive regulation of cell cycle	3	35	8.57142857142857	0.0139039173042954	0.0736009678602863	1	1	0.985133943562955	0.997102327989186	0.618825161444961
down	TERT; TGFB2; APLN;	GO:1902895~positive regulation of pri-miRNA transcription by RNA polymerase II	3	35	8.57142857142857	0.0139039173042954	0.0736009678602863	1	1	0.985133943562955	0.997102327989186	0.618825161444961
down	TERT; CSF2; GDNF;	GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	3	35	8.57142857142857	0.0139039173042954	0.0736009678602863	1	1	0.985133943562955	0.997102327989186	0.618825161444961
up	CCL22; XCL2; CCL8; CCL2; CCL24; CCL21; XCL1; CCL7;	GO:0048247~lymphocyte chemotaxis	8	33	24.2424242424242	0.0140490073171804	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
down	NQO1; NR2F2; PTGFR; MAP1B; POSTN;	GO:0032355~response to estradiol	5	103	4.85436893203883	0.0147834067305628	0.0754463515904583	1	1	0.990488250947706	0.997102327989186	0.634340852582602
down	TERT; SHH; SFRP1;	GO:0030177~positive regulation of Wnt signaling pathway	3	36	8.33333333333333	0.0149168047836509	0.0758195572437689	1	1	0.991609002346937	0.997102327989186	0.637478706001873
down	SLIT3; FLRT3; SEMA6D;	GO:0050919~negative chemotaxis	3	36	8.33333333333333	0.0149168047836509	0.0758195572437689	1	1	0.991609002346937	0.997102327989186	0.637478706001873
down	KCNJ5; FXYD3; KCNS3; KCNF1;	GO:0006813~potassium ion transport	4	68	5.88235294117647	0.01553981813631	0.0785104064878634	1	1	0.994901220693899	0.997102327989186	0.660102935904145
down	TGFB1I1; ONECUT2; CAV1; HTRA1;	GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway	4	68	5.88235294117647	0.01553981813631	0.0785104064878634	1	1	0.994901220693899	0.997102327989186	0.660102935904145
down	TGFB1I1; COL4A1; SIX1; GATA6;	GO:0030855~epithelial cell differentiation	4	68	5.88235294117647	0.01553981813631	0.0785104064878634	1	1	0.994901220693899	0.997102327989186	0.660102935904145
down	FXYD3; ANO4; ANO1;	GO:0006821~chloride transport	3	37	8.10810810810811	0.0159703220737843	0.0802730374045406	1	1	0.995904904144788	0.997102327989186	0.674922854626562
down	GJC1; MYL7; CALD1; MYOM3; NOS1;	GO:0006936~muscle contraction	5	106	4.71698113207547	0.0164629917729503	0.0802730374045406	1	1	0.99697663393133	0.997102327989186	0.674922854626562
down	INHA; INHBA; FOXL2;	GO:0001541~ovarian follicle development	3	38	7.89473684210526	0.0170646199326316	0.0822501604415732	1	1	0.997102327989186	0.997102327989186	0.691546188777694
down	SDC1; HS3ST2; GPC6;	GO:0006024~glycosaminoglycan biosynthetic process	3	38	7.89473684210526	0.0170646199326316	0.0822501604415732	1	1	0.997102327989186	0.997102327989186	0.691546188777694
down	WNT5A; WNT7B; ERN2;	GO:0007257~activation of JUN kinase activity	3	38	7.89473684210526	0.0170646199326316	0.0822501604415732	1	1	0.997102327989186	0.997102327989186	0.691546188777694
down	RBP1; HNF4A; ABCA12;	GO:0055088~lipid homeostasis	3	38	7.89473684210526	0.0170646199326316	0.0822501604415732	1	1	0.997102327989186	0.997102327989186	0.691546188777694
down	KCNJ5; CAV1; DSG2;	GO:0086091~regulation of heart rate by cardiac conduction	3	38	7.89473684210526	0.0170646199326316	0.0822501604415732	1	1	0.997102327989186	0.997102327989186	0.691546188777694
down	CDH11; GRIK2; PLCB4; NTF4;	GO:0050804~modulation of chemical synaptic transmission	4	71	5.63380281690141	0.0178020887996497	0.0856406413382767	1	1	0.997102327989186	0.997102327989186	0.720052809672427
down	EGFLAM; LAMC1; LAMA1;	GO:0009888~tissue development	3	39	7.69230769230769	0.0181998194335337	0.0866872523666455	1	1	0.997102327989186	0.997102327989186	0.728852547738777
down	TGFB2; SHH; HOXC10;	GO:0030326~embryonic limb morphogenesis	3	39	7.69230769230769	0.0181998194335337	0.0866872523666455	1	1	0.997102327989186	0.997102327989186	0.728852547738777
down	GPR37; IL11; ADRA1B; C1QTNF1; ROR1;	GO:0043410~positive regulation of MAPK cascade	5	109	4.58715596330275	0.0182647371783566	0.0866872523666455	1	1	0.997102327989186	0.997102327989186	0.728852547738777
down	SAA1; EDNRA; C1QTNF1; ADRA1D; ADRA1B; PTGFR;	GO:0007204~positive regulation of cytosolic calcium ion concentration	6	150	4	0.0182880443229678	0.0866872523666455	1	1	0.997102327989186	0.997102327989186	0.728852547738777
up	LILRA5; TRIM16; ORM1; LPL; ORM2; LILRA2; TLR8; NLRP7;	GO:0050718~positive regulation of interleukin-1 beta secretion	8	35	22.8571428571429	0.0185294076956539	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
down	CTSV; KRT20; SFRP1; PCSK9;	GO:0009267~cellular response to starvation	4	72	5.55555555555556	0.0185992305860969	0.0866872523666455	1	1	0.997102327989186	0.997102327989186	0.728852547738777
down	GLI3; SHH; SMO;	GO:0042307~positive regulation of protein import into nucleus	3	40	7.5	0.0193760129688065	0.0866872523666455	1	1	0.997102327989186	0.997102327989186	0.728852547738777
up	IL2RA; CTLA4; IL10; SDC4; IL20RB; LILRB2; LILRB1; GLMN; CD80;	GO:0042130~negative regulation of T cell proliferation	9	43	20.9302325581395	0.0202349365276865	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
down	CAV1; DUOXA2; TNS4; CCDC68;	GO:0008104~protein localization	4	74	5.40540540540541	0.0202590298138878	0.0866872523666455	1	1	0.997102327989186	0.997102327989186	0.728852547738777
down	CXCL14; BCAR1; ARHGEF16; SAA1;	GO:0060326~cell chemotaxis	4	74	5.40540540540541	0.0202590298138878	0.0866872523666455	1	1	0.997102327989186	0.997102327989186	0.728852547738777
up	LILRA5; IFNG; ORM1; LPL; ORM2; LILRA2;	GO:1904469~positive regulation of tumor necrosis factor secretion	6	22	27.2727272727273	0.0205659007368928	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
up	CNR2; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	3	5	60	0.02066912358753	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
up	IL10; IL18; BCL6B;	GO:0042092~type 2 immune response	3	5	60	0.02066912358753	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
down	NKX2-8; ONECUT2; PCSK9; GATA6;	GO:0001889~liver development	4	75	5.33333333333333	0.0211219727982559	0.0866872523666455	1	1	0.997102327989186	0.997102327989186	0.728852547738777
down	TGFB1I1; NOS1; CRNN;	GO:0009408~response to heat	3	42	7.14285714285714	0.0218516141569736	0.0866872523666455	1	1	0.997102327989186	0.997102327989186	0.728852547738777
down	STEAP2; FOXC2; NOS1;	GO:0009725~response to hormone	3	42	7.14285714285714	0.0218516141569736	0.0866872523666455	1	1	0.997102327989186	0.997102327989186	0.728852547738777
up	ALOX15B; TRIM16; FOXC1; OVOL2; IL20;	GO:0045618~positive regulation of keratinocyte differentiation	5	16	31.25	0.021852643057939	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
down	SAA1; TGFB2; CCL26; CXCL11;	GO:0030593~neutrophil chemotaxis	4	76	5.26315789473684	0.0220071221623681	0.0866872523666455	1	1	0.997102327989186	0.997102327989186	0.728852547738777
down	FGD1; PALLD; DLC1; SHROOM2; PDLIM4; PDLIM3;	GO:0030036~actin cytoskeleton organization	6	157	3.82165605095541	0.0221455630621368	0.0866872523666455	1	1	0.997102327989186	0.997102327989186	0.728852547738777
down	SCNN1G; FXYD3; SLC4A11; SLC6A15;	GO:0006814~sodium ion transport	4	77	5.19480519480519	0.0229146013822537	0.0866872523666455	1	1	0.997102327989186	0.997102327989186	0.728852547738777
down	NXN; GPX8; CYGB; PXDN;	GO:0098869~cellular oxidant detoxification	4	77	5.19480519480519	0.0229146013822537	0.0866872523666455	1	1	0.997102327989186	0.997102327989186	0.728852547738777
down	TBX3; STRA6; ANTXR1;	GO:0001568~blood vessel development	3	43	6.97674418604651	0.0231510718802626	0.0866872523666455	1	1	0.997102327989186	0.997102327989186	0.728852547738777
down	FGD1; CDC42EP5; BVES; FERMT2; DLC1; PARVA;	GO:0008360~regulation of cell shape	6	159	3.77358490566038	0.0233409724335348	0.0866872523666455	1	1	0.997102327989186	0.997102327989186	0.728852547738777
down	TGFB2; TWIST1; DLC1; VANGL2;	GO:0001843~neural tube closure	4	78	5.12820512820513	0.0238445262803156	0.0866872523666455	1	1	0.997102327989186	0.997102327989186	0.728852547738777
down	PTHLH; LGR4; TUFT1;	GO:0030282~bone mineralization	3	44	6.81818181818182	0.0244916256185252	0.0866872523666455	1	1	0.997102327989186	0.997102327989186	0.728852547738777
down	SHH; SIX1; SIX4;	GO:0048538~thymus development	3	44	6.81818181818182	0.0244916256185252	0.0866872523666455	1	1	0.997102327989186	0.997102327989186	0.728852547738777
down	RBFOX2; FGF1; FGF5; FLRT3;	GO:0008543~fibroblast growth factor receptor signaling pathway	4	79	5.06329113924051	0.0247970050685766	0.0866872523666455	1	1	0.997102327989186	0.997102327989186	0.728852547738777
down	SCNN1G; SHROOM2; NALCN; SLC4A11;	GO:0035725~sodium ion transmembrane transport	4	80	5	0.0257721383947648	0.0866872523666455	1	1	0.997102327989186	0.997102327989186	0.728852547738777
up	CCL22; EREG; F13A1; POMC; IL2RA; IGHG4; PF4; ANXA1; FCER2; CCL2; OSM; MUC1; IL1RN; IL10; PTPRZ1; CD80; IL13; OPRM1; FLT3; CCR2; FASLG; CEBPA; RORC; CCR5; IL5RA; IL18; IRF4; BATF; IL31; IL20RB; IL22; IL23A; IL26; IL20; IFNA5;	GO:0019221~cytokine-mediated signaling pathway	35	278	12.589928057554	0.0257938771005233	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
down	BCAR1; FHOD3; PDLIM3; SHROOM2; MYOM3;	GO:0007015~actin filament organization	5	121	4.13223140495868	0.0267536732466932	0.0878749894108095	1	1	0.997102327989186	0.997102327989186	0.738838850765446
down	XDH; CAV1; APLN;	GO:0007595~lactation	3	46	6.52173913043478	0.0272958507727193	0.0893060605255681	1	1	0.997102327989186	0.997102327989186	0.750871067723663
down	NR2F2; SHH; DLC1;	GO:0030900~forebrain development	3	46	6.52173913043478	0.0272958507727193	0.0893060605255681	1	1	0.997102327989186	0.997102327989186	0.750871067723663
down	TGFB1I1; MSX2; WNT5A;	GO:0045599~negative regulation of fat cell differentiation	3	46	6.52173913043478	0.0272958507727193	0.0893060605255681	1	1	0.997102327989186	0.997102327989186	0.750871067723663
down	FGF1; SAA1; GHR; WNT5A; CSPG4;	GO:0000187~activation of MAPK activity	5	122	4.0983606557377	0.0275570717116773	0.089926838426174	1	1	0.997102327989186	0.997102327989186	0.756090468986064
down	CXCL11; CXCL14; PLAU; FOSL1; CCL26;	GO:0006935~chemotaxis	5	122	4.0983606557377	0.0275570717116773	0.089926838426174	1	1	0.997102327989186	0.997102327989186	0.756090468986064
down	PLOD2; PLAT; FBXL2; LOXL2;	GO:0006464~cellular protein modification process	4	82	4.8780487804878	0.0277907337341133	0.0904547038486794	1	1	0.997102327989186	0.997102327989186	0.760528676998806
down	TGFB2; KRT17; SLC44A4; SFRP1;	GO:0030307~positive regulation of cell growth	4	82	4.8780487804878	0.0277907337341133	0.0904547038486794	1	1	0.997102327989186	0.997102327989186	0.760528676998806
up	EREG; EGFR; ERBB3; BTC; MATK; PTK6; GRB7;	GO:0038128~ERBB2 signaling pathway	7	31	22.5806451612903	0.0281816311585803	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
up	PF4; IL10; IRF8; IRF4; BATF; GBP7;	GO:0042832~defense response to protozoan	6	24	25	0.0283176031930099	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
down	CCK; HRH1; NDRG4;	GO:0008542~visual learning	3	47	6.38297872340426	0.0287593799512802	0.091477370363364	1	1	0.997102327989186	0.997102327989186	0.769127093425278
down	UCN2; CGB7; LGR4;	GO:0009755~hormone-mediated signaling pathway	3	47	6.38297872340426	0.0287593799512802	0.091477370363364	1	1	0.997102327989186	0.997102327989186	0.769127093425278
down	NXN; SFRP1; APCDD1L;	GO:0030178~negative regulation of Wnt signaling pathway	3	47	6.38297872340426	0.0287593799512802	0.091477370363364	1	1	0.997102327989186	0.997102327989186	0.769127093425278
up	CD19; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	3	6	50	0.0291982964204087	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
up	DSP; GRHL1; PERP;	GO:0002934~desmosome organization	3	6	50	0.0291982964204087	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
up	PF4; SPI1; IL10;	GO:0045347~negative regulation of MHC class II biosynthetic process	3	6	50	0.0291982964204087	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
up	DSP; TJP1; CGNL1;	GO:0150105~protein localization to cell-cell junction	3	6	50	0.0291982964204087	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
up	IFNG; CCL2; CCR2;	GO:1904783~positive regulation of NMDA glutamate receptor activity	3	6	50	0.0291982964204087	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
up	FCGR2B; TMEM176B; LILRB1;	GO:2001199~negative regulation of dendritic cell differentiation	3	6	50	0.0291982964204087	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
down	POSTN; SFRP1; HAS2; ADAMTS7; CCL26;	GO:0071356~cellular response to tumor necrosis factor	5	125	4	0.0300585606714816	0.0954890639513229	1	1	0.997102327989186	0.997102327989186	0.802856771232625
down	INHBA; TGFB2; INHA;	GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation	3	48	6.25	0.0302637223337526	0.09589864658907	1	1	0.997102327989186	0.997102327989186	0.806300476516638
down	LHX1; CNTN1; CDK5R2;	GO:0021549~cerebellum development	3	48	6.25	0.0302637223337526	0.09589864658907	1	1	0.997102327989186	0.997102327989186	0.806300476516638
up	SPI1; IRF4; BATF; DCSTAMP; BATF3;	GO:0043011~myeloid dendritic cell differentiation	5	18	27.7777777777778	0.0316808023632824	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
down	PTHLH; FOSL1; COL16A1; TFCP2L1;	GO:0007565~female pregnancy	4	86	4.65116279069767	0.0321033802085033	0.100587926033119	1	1	0.997102327989186	0.997102327989186	0.845727187786692
down	EFNA2; MMP2; EFNB2; EFNB3;	GO:0048013~ephrin receptor signaling pathway	4	86	4.65116279069767	0.0321033802085033	0.100587926033119	1	1	0.997102327989186	0.997102327989186	0.845727187786692
up	CD40LG; XCL1; TIGIT; IL20RB; TSLP; IL23A;	GO:0032733~positive regulation of interleukin-10 production	6	25	24	0.0328275565678323	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
down	CCK; F3; XDH; DLC1;	GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process	4	87	4.59770114942529	0.0332392894553897	0.102612705741372	1	1	0.997102327989186	0.997102327989186	0.862751211604268
down	CSF3; SOX9; TGFB2; ROR1;	GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling	4	87	4.59770114942529	0.0332392894553897	0.102612705741372	1	1	0.997102327989186	0.997102327989186	0.862751211604268
up	LTF; GATA1; SOX8; TMEM119;	GO:0033690~positive regulation of osteoblast proliferation	4	12	33.3333333333333	0.0333290095658787	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
up	IL2RA; CTLA4; FCGR2B; SPINK5;	GO:0050777~negative regulation of immune response	4	12	33.3333333333333	0.0333290095658787	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
down	WNT5A; ROR1; PRICKLE2; GPC6;	GO:0060071~Wnt signaling pathway, planar cell polarity pathway	4	88	4.54545454545455	0.0343983928490903	0.102612705741372	1	1	0.997102327989186	0.997102327989186	0.862751211604268
down	CSF3; CDC42EP5; CCL26;	GO:0030838~positive regulation of actin filament polymerization	3	51	5.88235294117647	0.0350202852209691	0.102612705741372	1	1	0.997102327989186	0.997102327989186	0.862751211604268
down	VIP; SIX1; SIX4;	GO:0032880~regulation of protein localization	3	51	5.88235294117647	0.0350202852209691	0.102612705741372	1	1	0.997102327989186	0.997102327989186	0.862751211604268
down	INHA; INHBA; TGFB2; ERN2; BTG4;	GO:0007050~cell cycle arrest	5	131	3.81679389312977	0.0354784289627456	0.102612705741372	1	1	0.997102327989186	0.997102327989186	0.862751211604268
down	COL4A2; THBS2; TGFB2; PLK2;	GO:0016525~negative regulation of angiogenesis	4	89	4.49438202247191	0.0355807256151068	0.102612705741372	1	1	0.997102327989186	0.997102327989186	0.862751211604268
up	LTF; RNASE3; DEFA3; DEFB1; DEFA4;	GO:0002227~innate immune response in mucosa	5	19	26.3157894736842	0.0374801343420111	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
down	EFNB2; CAV1; EFNB3;	GO:0031295~T cell costimulation	3	53	5.66037735849057	0.0383925947700103	0.102612705741372	1	1	0.997102327989186	0.997102327989186	0.862751211604268
down	CAV1; NXN; RASD2;	GO:0031397~negative regulation of protein ubiquitination	3	53	5.66037735849057	0.0383925947700103	0.102612705741372	1	1	0.997102327989186	0.997102327989186	0.862751211604268
down	CSF3; DPYSL3; CRNN;	GO:0071345~cellular response to cytokine stimulus	3	53	5.66037735849057	0.0383925947700103	0.102612705741372	1	1	0.997102327989186	0.997102327989186	0.862751211604268
up	ALOX15B; PRLR; CD24;	GO:0030856~regulation of epithelial cell differentiation	3	7	42.8571428571429	0.0392940652380935	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
up	FCGR2B; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	3	7	42.8571428571429	0.0392940652380935	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
up	HP; GZMA; GZMK;	GO:0051354~negative regulation of oxidoreductase activity	3	7	42.8571428571429	0.0392940652380935	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
up	IFNG; PAX6; FOXC1;	GO:1904798~positive regulation of core promoter binding	3	7	42.8571428571429	0.0392940652380935	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
down	SPDEF; FOSL1; HMGA2; FOXL2; FGD1; ARHGEF16; SFRP1; CSRNP3; NOX4;	GO:0043065~positive regulation of apoptotic process	9	332	2.71084337349398	0.0398354356507967	0.103579565177608	1	1	0.997102327989186	0.997102327989186	0.870880411044404
up	CRYBA1; IL10; CLEC4A; NDRG2;	GO:0001818~negative regulation of cytokine production	4	13	30.7692307692308	0.0409184558980595	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
up	PTGES; APOA2; HP; HPR;	GO:0002526~acute inflammatory response	4	13	30.7692307692308	0.0409184558980595	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
up	ADRB2; PRLR; EFNA5; ANGPT1;	GO:0007171~activation of transmembrane receptor protein tyrosine kinase activity	4	13	30.7692307692308	0.0409184558980595	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
down	SOX15; HMGA2; ZNF462; PADI3; FOXA2;	GO:0006325~chromatin organization	5	139	3.59712230215827	0.0435866210679057	0.111787908875485	1	1	0.997102327989186	0.997102327989186	0.939894851502263
down	WNT5A; SOX9; DLX2;	GO:0051216~cartilage development	3	58	5.17241379310345	0.0475152162480648	0.11686219607208	1	1	0.997102327989186	0.997102327989186	0.982558646353596
down	ABCA12; MRAP2; EHD2; KCNIP3; RAB3B;	GO:0072659~protein localization to plasma membrane	5	144	3.47222222222222	0.0491735503493917	0.11686219607208	1	1	0.997102327989186	0.997102327989186	0.982558646353596
down	CDH3; CAV1; SFRP1; LGR4; LYPD6;	GO:0090263~positive regulation of canonical Wnt signaling pathway	5	144	3.47222222222222	0.0491735503493917	0.11686219607208	1	1	0.997102327989186	0.997102327989186	0.982558646353596
up	P2RY10; GPR171; P2RY13; P2RY12;	GO:0035589~G protein-coupled purinergic nucleotide receptor signaling pathway	4	14	28.5714285714286	0.0494028651526855	0.901356593697302	1	1	0.999999999999997	0.999999999999997	1
down	NKX3-2; DNAH5; BICC1;	GO:0007368~determination of left/right symmetry	3	59	5.08474576271187	0.04945626908778	0.11686219607208	1	1	0.997102327989186	0.997102327989186	0.982558646353596
down	WNT5A; DUOXA2; FRMD6;	GO:0034613~cellular protein localization	3	59	5.08474576271187	0.04945626908778	0.11686219607208	1	1	0.997102327989186	0.997102327989186	0.982558646353596
